nodes	percent_of_prediction	percent_of_DWPC	metapath
Erythromycin—ABCC1—Vemurafenib—skin cancer	0.141	0.165	CbGbCtD
Erythromycin—ABCC1—Dactinomycin—skin cancer	0.094	0.11	CbGbCtD
Erythromycin—SLC22A7—Fluorouracil—skin cancer	0.0809	0.0945	CbGbCtD
Erythromycin—CYP1A2—Imiquimod—skin cancer	0.0712	0.0832	CbGbCtD
Erythromycin—SLC22A7—Docetaxel—skin cancer	0.0618	0.0722	CbGbCtD
Erythromycin—ABCC1—Docetaxel—skin cancer	0.0485	0.0567	CbGbCtD
Erythromycin—ABCB1—Vismodegib—skin cancer	0.0432	0.0504	CbGbCtD
Erythromycin—CYP1A2—Vemurafenib—skin cancer	0.039	0.0456	CbGbCtD
Erythromycin—CYP3A4—Imiquimod—skin cancer	0.0373	0.0436	CbGbCtD
Erythromycin—CYP3A4—Temozolomide—skin cancer	0.0373	0.0436	CbGbCtD
Erythromycin—CYP1A2—Dacarbazine—skin cancer	0.0299	0.0349	CbGbCtD
Erythromycin—CYP3A4—Vismodegib—skin cancer	0.0259	0.0302	CbGbCtD
Erythromycin—CYP3A7—Docetaxel—skin cancer	0.024	0.028	CbGbCtD
Erythromycin—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.024	0.028	CbGbCtD
Erythromycin—ABCB1—Dactinomycin—skin cancer	0.0227	0.0265	CbGbCtD
Erythromycin—CYP3A4—Vemurafenib—skin cancer	0.0204	0.0239	CbGbCtD
Erythromycin—CYP3A5—Docetaxel—skin cancer	0.018	0.021	CbGbCtD
Erythromycin—CYP1A2—Fluorouracil—skin cancer	0.0175	0.0205	CbGbCtD
Erythromycin—ABCB1—Docetaxel—skin cancer	0.0117	0.0137	CbGbCtD
Erythromycin—Skin tenderness—Bleomycin—skin cancer	0.0116	0.0806	CcSEcCtD
Erythromycin—CYP3A4—Docetaxel—skin cancer	0.00701	0.0082	CbGbCtD
Erythromycin—Pain of skin—Bleomycin—skin cancer	0.00569	0.0394	CcSEcCtD
Erythromycin—Localized exfoliation—Bleomycin—skin cancer	0.00497	0.0345	CcSEcCtD
Erythromycin—Superinfection—Fluorouracil—skin cancer	0.00459	0.0318	CcSEcCtD
Erythromycin—Electrocardiogram QT prolonged—Vemurafenib—skin cancer	0.00344	0.0239	CcSEcCtD
Erythromycin—Hepatotoxicity—Vemurafenib—skin cancer	0.00286	0.0199	CcSEcCtD
Erythromycin—Trauma—Bleomycin—skin cancer	0.00281	0.0195	CcSEcCtD
Erythromycin—Skin irritation—Fluorouracil—skin cancer	0.00241	0.0167	CcSEcCtD
Erythromycin—Tenderness—Imiquimod—skin cancer	0.00216	0.015	CcSEcCtD
Erythromycin—Eruption—Dactinomycin—skin cancer	0.00203	0.0141	CcSEcCtD
Erythromycin—Skin exfoliation—Imiquimod—skin cancer	0.0018	0.0125	CcSEcCtD
Erythromycin—Hepatotoxicity—Dactinomycin—skin cancer	0.00162	0.0112	CcSEcCtD
Erythromycin—Hepatic function abnormal—Imiquimod—skin cancer	0.00157	0.0109	CcSEcCtD
Erythromycin—Tenderness—Bleomycin—skin cancer	0.00154	0.0107	CcSEcCtD
Erythromycin—Dysgeusia—Vismodegib—skin cancer	0.00153	0.0106	CcSEcCtD
Erythromycin—Injury—Imiquimod—skin cancer	0.00149	0.0103	CcSEcCtD
Erythromycin—Hepatotoxicity—Temozolomide—skin cancer	0.00146	0.0102	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.00145	0.01	CcSEcCtD
Erythromycin—Irritability—Imiquimod—skin cancer	0.00131	0.00907	CcSEcCtD
Erythromycin—Skin exfoliation—Bleomycin—skin cancer	0.00128	0.00887	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00123	0.00851	CcSEcCtD
Erythromycin—Eruption—Docetaxel—skin cancer	0.00122	0.00848	CcSEcCtD
Erythromycin—Eye irritation—Fluorouracil—skin cancer	0.00122	0.00846	CcSEcCtD
Erythromycin—Tenderness—Fluorouracil—skin cancer	0.00119	0.00828	CcSEcCtD
Erythromycin—Hearing impaired—Temozolomide—skin cancer	0.00119	0.00824	CcSEcCtD
Erythromycin—Redness—Docetaxel—skin cancer	0.00111	0.00772	CcSEcCtD
Erythromycin—Decreased appetite—Vismodegib—skin cancer	0.00111	0.0077	CcSEcCtD
Erythromycin—Pain—Vismodegib—skin cancer	0.00109	0.00758	CcSEcCtD
Erythromycin—Burning sensation—Docetaxel—skin cancer	0.00108	0.00751	CcSEcCtD
Erythromycin—Skin exfoliation—Temozolomide—skin cancer	0.00108	0.00749	CcSEcCtD
Erythromycin—Injury—Bleomycin—skin cancer	0.00106	0.00734	CcSEcCtD
Erythromycin—Erythema multiforme—Vemurafenib—skin cancer	0.00105	0.00728	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00105	0.00726	CcSEcCtD
Erythromycin—Gastrointestinal pain—Vismodegib—skin cancer	0.00104	0.00724	CcSEcCtD
Erythromycin—Abdominal pain—Vismodegib—skin cancer	0.00101	0.007	CcSEcCtD
Erythromycin—Hepatotoxicity—Docetaxel—skin cancer	0.000973	0.00675	CcSEcCtD
Erythromycin—Erythema—Vemurafenib—skin cancer	0.000967	0.00671	CcSEcCtD
Erythromycin—Dysgeusia—Vemurafenib—skin cancer	0.000947	0.00657	CcSEcCtD
Erythromycin—Deafness—Temozolomide—skin cancer	0.000917	0.00636	CcSEcCtD
Erythromycin—Pruritus—Vismodegib—skin cancer	0.000903	0.00627	CcSEcCtD
Erythromycin—Erythema multiforme—Imiquimod—skin cancer	0.000895	0.00621	CcSEcCtD
Erythromycin—Tinnitus—Imiquimod—skin cancer	0.000883	0.00613	CcSEcCtD
Erythromycin—Eye irritation—Docetaxel—skin cancer	0.00088	0.00611	CcSEcCtD
Erythromycin—Diarrhoea—Vismodegib—skin cancer	0.000874	0.00606	CcSEcCtD
Erythromycin—Arrhythmia—Imiquimod—skin cancer	0.000846	0.00587	CcSEcCtD
Erythromycin—Liver function test abnormal—Dactinomycin—skin cancer	0.000837	0.00581	CcSEcCtD
Erythromycin—Erythema—Imiquimod—skin cancer	0.000824	0.00572	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.000817	0.00567	CcSEcCtD
Erythromycin—Vomiting—Vismodegib—skin cancer	0.000812	0.00563	CcSEcCtD
Erythromycin—Rash—Vismodegib—skin cancer	0.000805	0.00559	CcSEcCtD
Erythromycin—Hearing impaired—Docetaxel—skin cancer	0.000789	0.00548	CcSEcCtD
Erythromycin—Anaphylactic shock—Vemurafenib—skin cancer	0.000789	0.00547	CcSEcCtD
Erythromycin—Nausea—Vismodegib—skin cancer	0.000758	0.00526	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.000739	0.00513	CcSEcCtD
Erythromycin—Palpitations—Imiquimod—skin cancer	0.000728	0.00505	CcSEcCtD
Erythromycin—Irritability—Fluorouracil—skin cancer	0.000721	0.00501	CcSEcCtD
Erythromycin—Skin exfoliation—Docetaxel—skin cancer	0.000717	0.00498	CcSEcCtD
Erythromycin—Convulsion—Imiquimod—skin cancer	0.000714	0.00496	CcSEcCtD
Erythromycin—Chest pain—Imiquimod—skin cancer	0.000702	0.00487	CcSEcCtD
Erythromycin—Discomfort—Imiquimod—skin cancer	0.000693	0.00481	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000693	0.00481	CcSEcCtD
Erythromycin—Decreased appetite—Vemurafenib—skin cancer	0.000686	0.00476	CcSEcCtD
Erythromycin—Anorexia—Imiquimod—skin cancer	0.000641	0.00445	CcSEcCtD
Erythromycin—Hepatitis—Dactinomycin—skin cancer	0.000627	0.00435	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000627	0.00435	CcSEcCtD
Erythromycin—Deafness—Docetaxel—skin cancer	0.00061	0.00423	CcSEcCtD
Erythromycin—Erythema multiforme—Dactinomycin—skin cancer	0.000593	0.00412	CcSEcCtD
Erythromycin—Erythema—Bleomycin—skin cancer	0.000586	0.00406	CcSEcCtD
Erythromycin—Decreased appetite—Imiquimod—skin cancer	0.000585	0.00406	CcSEcCtD
Erythromycin—Hypersensitivity—Vemurafenib—skin cancer	0.000581	0.00403	CcSEcCtD
Erythromycin—Pain—Imiquimod—skin cancer	0.000575	0.00399	CcSEcCtD
Erythromycin—Hepatitis—Temozolomide—skin cancer	0.000567	0.00394	CcSEcCtD
Erythromycin—Hallucination—Temozolomide—skin cancer	0.000565	0.00392	CcSEcCtD
Erythromycin—Pruritus—Vemurafenib—skin cancer	0.000558	0.00387	CcSEcCtD
Erythromycin—Feeling abnormal—Imiquimod—skin cancer	0.000554	0.00385	CcSEcCtD
Erythromycin—Gastrointestinal pain—Imiquimod—skin cancer	0.00055	0.00382	CcSEcCtD
Erythromycin—Erythema—Dactinomycin—skin cancer	0.000546	0.00379	CcSEcCtD
Erythromycin—Diarrhoea—Vemurafenib—skin cancer	0.00054	0.00375	CcSEcCtD
Erythromycin—Erythema multiforme—Temozolomide—skin cancer	0.000537	0.00372	CcSEcCtD
Erythromycin—Urticaria—Imiquimod—skin cancer	0.000534	0.00371	CcSEcCtD
Erythromycin—Abdominal pain—Imiquimod—skin cancer	0.000532	0.00369	CcSEcCtD
Erythromycin—Tinnitus—Temozolomide—skin cancer	0.000529	0.00367	CcSEcCtD
Erythromycin—Dizziness—Vemurafenib—skin cancer	0.000522	0.00362	CcSEcCtD
Erythromycin—Liver function test abnormal—Docetaxel—skin cancer	0.000504	0.00349	CcSEcCtD
Erythromycin—Vomiting—Vemurafenib—skin cancer	0.000502	0.00348	CcSEcCtD
Erythromycin—Chest pain—Bleomycin—skin cancer	0.000499	0.00346	CcSEcCtD
Erythromycin—Rash—Vemurafenib—skin cancer	0.000497	0.00345	CcSEcCtD
Erythromycin—Hypersensitivity—Imiquimod—skin cancer	0.000496	0.00344	CcSEcCtD
Erythromycin—Erythema—Temozolomide—skin cancer	0.000494	0.00343	CcSEcCtD
Erythromycin—Discomfort—Bleomycin—skin cancer	0.000493	0.00342	CcSEcCtD
Erythromycin—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000491	0.00341	CcSEcCtD
Erythromycin—Dysgeusia—Temozolomide—skin cancer	0.000484	0.00336	CcSEcCtD
Erythromycin—Confusional state—Bleomycin—skin cancer	0.000482	0.00334	CcSEcCtD
Erythromycin—Anaphylactic shock—Bleomycin—skin cancer	0.000478	0.00332	CcSEcCtD
Erythromycin—Pruritus—Imiquimod—skin cancer	0.000476	0.0033	CcSEcCtD
Erythromycin—Nausea—Vemurafenib—skin cancer	0.000469	0.00325	CcSEcCtD
Erythromycin—Arrhythmia—Fluorouracil—skin cancer	0.000467	0.00324	CcSEcCtD
Erythromycin—Diarrhoea—Imiquimod—skin cancer	0.00046	0.00319	CcSEcCtD
Erythromycin—Discomfort—Dactinomycin—skin cancer	0.000459	0.00319	CcSEcCtD
Erythromycin—Anorexia—Bleomycin—skin cancer	0.000456	0.00316	CcSEcCtD
Erythromycin—Erythema—Fluorouracil—skin cancer	0.000455	0.00316	CcSEcCtD
Erythromycin—Dizziness—Imiquimod—skin cancer	0.000445	0.00309	CcSEcCtD
Erythromycin—Vertigo—Temozolomide—skin cancer	0.000444	0.00308	CcSEcCtD
Erythromycin—Palpitations—Temozolomide—skin cancer	0.000437	0.00303	CcSEcCtD
Erythromycin—Convulsion—Temozolomide—skin cancer	0.000428	0.00297	CcSEcCtD
Erythromycin—Vomiting—Imiquimod—skin cancer	0.000428	0.00297	CcSEcCtD
Erythromycin—Anorexia—Dactinomycin—skin cancer	0.000425	0.00295	CcSEcCtD
Erythromycin—Rash—Imiquimod—skin cancer	0.000424	0.00294	CcSEcCtD
Erythromycin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000417	0.00289	CcSEcCtD
Erythromycin—Discomfort—Temozolomide—skin cancer	0.000416	0.00288	CcSEcCtD
Erythromycin—Decreased appetite—Bleomycin—skin cancer	0.000415	0.00288	CcSEcCtD
Erythromycin—Jaundice—Docetaxel—skin cancer	0.00041	0.00284	CcSEcCtD
Erythromycin—Pain—Bleomycin—skin cancer	0.000409	0.00284	CcSEcCtD
Erythromycin—Confusional state—Temozolomide—skin cancer	0.000407	0.00282	CcSEcCtD
Erythromycin—Anaphylactic shock—Temozolomide—skin cancer	0.000403	0.0028	CcSEcCtD
Erythromycin—Nausea—Imiquimod—skin cancer	0.0004	0.00277	CcSEcCtD
Erythromycin—Convulsion—Fluorouracil—skin cancer	0.000394	0.00274	CcSEcCtD
Erythromycin—Feeling abnormal—Bleomycin—skin cancer	0.000394	0.00273	CcSEcCtD
Erythromycin—Chest pain—Fluorouracil—skin cancer	0.000387	0.00269	CcSEcCtD
Erythromycin—Decreased appetite—Dactinomycin—skin cancer	0.000387	0.00269	CcSEcCtD
Erythromycin—Anorexia—Temozolomide—skin cancer	0.000384	0.00267	CcSEcCtD
Erythromycin—Discomfort—Fluorouracil—skin cancer	0.000383	0.00266	CcSEcCtD
Erythromycin—Pain—Dactinomycin—skin cancer	0.000381	0.00264	CcSEcCtD
Erythromycin—Urticaria—Bleomycin—skin cancer	0.00038	0.00263	CcSEcCtD
Erythromycin—Hepatitis—Docetaxel—skin cancer	0.000377	0.00262	CcSEcCtD
Erythromycin—Confusional state—Fluorouracil—skin cancer	0.000375	0.0026	CcSEcCtD
Erythromycin—Anaphylactic shock—Fluorouracil—skin cancer	0.000371	0.00258	CcSEcCtD
Erythromycin—Feeling abnormal—Dactinomycin—skin cancer	0.000367	0.00255	CcSEcCtD
Erythromycin—Gastrointestinal pain—Dactinomycin—skin cancer	0.000364	0.00253	CcSEcCtD
Erythromycin—Erythema multiforme—Docetaxel—skin cancer	0.000357	0.00248	CcSEcCtD
Erythromycin—Anorexia—Fluorouracil—skin cancer	0.000354	0.00246	CcSEcCtD
Erythromycin—Abdominal pain—Dactinomycin—skin cancer	0.000352	0.00244	CcSEcCtD
Erythromycin—Hypersensitivity—Bleomycin—skin cancer	0.000352	0.00244	CcSEcCtD
Erythromycin—Decreased appetite—Temozolomide—skin cancer	0.00035	0.00243	CcSEcCtD
Erythromycin—Pain—Temozolomide—skin cancer	0.000345	0.00239	CcSEcCtD
Erythromycin—Pruritus—Bleomycin—skin cancer	0.000338	0.00235	CcSEcCtD
Erythromycin—Arrhythmia—Docetaxel—skin cancer	0.000337	0.00234	CcSEcCtD
Erythromycin—Feeling abnormal—Temozolomide—skin cancer	0.000332	0.00231	CcSEcCtD
Erythromycin—Gastrointestinal pain—Temozolomide—skin cancer	0.00033	0.00229	CcSEcCtD
Erythromycin—Erythema—Docetaxel—skin cancer	0.000329	0.00228	CcSEcCtD
Erythromycin—Hypersensitivity—Dactinomycin—skin cancer	0.000328	0.00228	CcSEcCtD
Erythromycin—Decreased appetite—Fluorouracil—skin cancer	0.000323	0.00224	CcSEcCtD
Erythromycin—Dysgeusia—Docetaxel—skin cancer	0.000322	0.00223	CcSEcCtD
Erythromycin—Urticaria—Temozolomide—skin cancer	0.00032	0.00222	CcSEcCtD
Erythromycin—Abdominal pain—Temozolomide—skin cancer	0.000319	0.00221	CcSEcCtD
Erythromycin—Pain—Fluorouracil—skin cancer	0.000318	0.0022	CcSEcCtD
Erythromycin—Feeling abnormal—Fluorouracil—skin cancer	0.000306	0.00212	CcSEcCtD
Erythromycin—Diarrhoea—Dactinomycin—skin cancer	0.000305	0.00212	CcSEcCtD
Erythromycin—Vomiting—Bleomycin—skin cancer	0.000304	0.00211	CcSEcCtD
Erythromycin—Rash—Bleomycin—skin cancer	0.000301	0.00209	CcSEcCtD
Erythromycin—Hypersensitivity—Temozolomide—skin cancer	0.000297	0.00206	CcSEcCtD
Erythromycin—Urticaria—Fluorouracil—skin cancer	0.000295	0.00205	CcSEcCtD
Erythromycin—Palpitations—Docetaxel—skin cancer	0.00029	0.00201	CcSEcCtD
Erythromycin—Pruritus—Temozolomide—skin cancer	0.000285	0.00198	CcSEcCtD
Erythromycin—Convulsion—Docetaxel—skin cancer	0.000285	0.00197	CcSEcCtD
Erythromycin—Nausea—Bleomycin—skin cancer	0.000284	0.00197	CcSEcCtD
Erythromycin—Vomiting—Dactinomycin—skin cancer	0.000283	0.00197	CcSEcCtD
Erythromycin—Rash—Dactinomycin—skin cancer	0.000281	0.00195	CcSEcCtD
Erythromycin—Chest pain—Docetaxel—skin cancer	0.00028	0.00194	CcSEcCtD
Erythromycin—Diarrhoea—Temozolomide—skin cancer	0.000276	0.00191	CcSEcCtD
Erythromycin—Hypersensitivity—Fluorouracil—skin cancer	0.000274	0.0019	CcSEcCtD
Erythromycin—Confusional state—Docetaxel—skin cancer	0.00027	0.00188	CcSEcCtD
Erythromycin—Anaphylactic shock—Docetaxel—skin cancer	0.000268	0.00186	CcSEcCtD
Erythromycin—Dizziness—Temozolomide—skin cancer	0.000267	0.00185	CcSEcCtD
Erythromycin—Nausea—Dactinomycin—skin cancer	0.000265	0.00184	CcSEcCtD
Erythromycin—Pruritus—Fluorouracil—skin cancer	0.000263	0.00182	CcSEcCtD
Erythromycin—Vomiting—Temozolomide—skin cancer	0.000256	0.00178	CcSEcCtD
Erythromycin—Anorexia—Docetaxel—skin cancer	0.000256	0.00177	CcSEcCtD
Erythromycin—Rash—Temozolomide—skin cancer	0.000254	0.00176	CcSEcCtD
Erythromycin—Diarrhoea—Fluorouracil—skin cancer	0.000254	0.00176	CcSEcCtD
Erythromycin—Dizziness—Fluorouracil—skin cancer	0.000246	0.0017	CcSEcCtD
Erythromycin—Nausea—Temozolomide—skin cancer	0.000239	0.00166	CcSEcCtD
Erythromycin—Vomiting—Fluorouracil—skin cancer	0.000236	0.00164	CcSEcCtD
Erythromycin—Rash—Fluorouracil—skin cancer	0.000234	0.00163	CcSEcCtD
Erythromycin—Decreased appetite—Docetaxel—skin cancer	0.000233	0.00162	CcSEcCtD
Erythromycin—Pain—Docetaxel—skin cancer	0.000229	0.00159	CcSEcCtD
Erythromycin—Feeling abnormal—Docetaxel—skin cancer	0.000221	0.00153	CcSEcCtD
Erythromycin—Nausea—Fluorouracil—skin cancer	0.000221	0.00153	CcSEcCtD
Erythromycin—Gastrointestinal pain—Docetaxel—skin cancer	0.000219	0.00152	CcSEcCtD
Erythromycin—Abdominal pain—Docetaxel—skin cancer	0.000212	0.00147	CcSEcCtD
Erythromycin—Hypersensitivity—Docetaxel—skin cancer	0.000198	0.00137	CcSEcCtD
Erythromycin—Pruritus—Docetaxel—skin cancer	0.00019	0.00132	CcSEcCtD
Erythromycin—Diarrhoea—Docetaxel—skin cancer	0.000183	0.00127	CcSEcCtD
Erythromycin—Dizziness—Docetaxel—skin cancer	0.000177	0.00123	CcSEcCtD
Erythromycin—Vomiting—Docetaxel—skin cancer	0.00017	0.00118	CcSEcCtD
Erythromycin—Rash—Docetaxel—skin cancer	0.000169	0.00117	CcSEcCtD
Erythromycin—Nausea—Docetaxel—skin cancer	0.000159	0.0011	CcSEcCtD
